MX2018001251A - Respuesta inmunitaria potenciada de las especies porcinas. - Google Patents
Respuesta inmunitaria potenciada de las especies porcinas.Info
- Publication number
- MX2018001251A MX2018001251A MX2018001251A MX2018001251A MX2018001251A MX 2018001251 A MX2018001251 A MX 2018001251A MX 2018001251 A MX2018001251 A MX 2018001251A MX 2018001251 A MX2018001251 A MX 2018001251A MX 2018001251 A MX2018001251 A MX 2018001251A
- Authority
- MX
- Mexico
- Prior art keywords
- immune response
- porcine species
- enhanced immune
- subject
- porcine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La presente invención se refiere generalmente a métodos para provocar una respuesta inmunitaria en un sujeto de la especie porcina. En particular, una composición inmunomoduladora se usa para inducir una respuesta inmunitaria para mejorar la capacidad del sujeto de combatir los patógenos infecciosos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562199848P | 2015-07-31 | 2015-07-31 | |
PCT/EP2016/067971 WO2017021266A1 (en) | 2015-07-31 | 2016-07-28 | Enhanced immune response in porcine species |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018001251A true MX2018001251A (es) | 2018-03-26 |
Family
ID=56682095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018001251A MX2018001251A (es) | 2015-07-31 | 2016-07-28 | Respuesta inmunitaria potenciada de las especies porcinas. |
Country Status (18)
Country | Link |
---|---|
US (1) | US11439703B2 (es) |
EP (1) | EP3328424A1 (es) |
JP (1) | JP2018521109A (es) |
KR (1) | KR20180036765A (es) |
CN (1) | CN108025062A (es) |
AR (1) | AR105568A1 (es) |
AU (1) | AU2016302436B2 (es) |
BR (1) | BR112018002107A2 (es) |
CA (1) | CA2993883A1 (es) |
CL (1) | CL2018000253A1 (es) |
HK (1) | HK1255052A1 (es) |
IL (1) | IL256984A (es) |
MX (1) | MX2018001251A (es) |
PH (1) | PH12018500201A1 (es) |
SG (1) | SG10202000891UA (es) |
TW (1) | TW201718001A (es) |
WO (1) | WO2017021266A1 (es) |
ZA (1) | ZA201801338B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112019001599A2 (pt) | 2016-07-26 | 2019-10-01 | Bayer Animal Health Gmbh | fertilidade aumentada em espécies bovinas |
CA3197650A1 (en) * | 2020-10-02 | 2022-04-07 | Celsion Corporation | Polynucleotide vaccines and methods of using the same |
WO2023224882A1 (en) * | 2022-05-17 | 2023-11-23 | Elanco Us Inc. | Methods for predicting efficacy of a modified live porcine reproductive and respiratory syndrome virus (prrsv) vaccine |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
ATE370740T1 (de) * | 1997-05-20 | 2007-09-15 | Ottawa Health Research Inst | Verfahren zur herstellung von nukleinsäurekonstrukten |
US20040247662A1 (en) | 1998-06-25 | 2004-12-09 | Dow Steven W. | Systemic immune activation method using nucleic acid-lipid complexes |
US20030022854A1 (en) | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
US6693086B1 (en) | 1998-06-25 | 2004-02-17 | National Jewish Medical And Research Center | Systemic immune activation method using nucleic acid-lipid complexes |
ATE549032T1 (de) | 1999-03-26 | 2012-03-15 | Vical Inc | Adjuvanzverbindungen zur verbesserung von immunreaktionen auf polynukleotid-basierten impfstoffen |
HU221664B1 (hu) * | 1999-03-31 | 2002-12-28 | MTA Állatorvostudományi Kutatóintézete | Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás |
US20040002472A1 (en) | 2000-01-21 | 2004-01-01 | Audonnet Jean-Christophe Francis | Vaccination or immunization using a prime-boost regimen |
CA2437899C (en) * | 2001-02-13 | 2012-05-15 | Gregory M. Glenn | Vaccine for transcutaneous immunization against etec-caused traveler's diarrhea |
PL1605971T3 (pl) | 2003-03-26 | 2010-10-29 | Wyeth Llc | Kompozycja immunogenna i sposoby |
AU2004280143A1 (en) | 2003-10-11 | 2005-04-21 | Tekmira Pharmaceuticals Corporation | Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
US20050181035A1 (en) | 2004-02-17 | 2005-08-18 | Dow Steven W. | Systemic immune activation method using non CpG nucleic acids |
US20060135457A1 (en) | 2004-08-13 | 2006-06-22 | Yvonne Paterson | Methods for constructing antibiotic resistance free vaccines |
EP2249843A4 (en) * | 2008-02-24 | 2013-05-08 | Us Gov Health & Human Serv | USE OF IMMUNOGENIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOGENIC INFECTIONS |
WO2009120811A1 (en) | 2008-03-25 | 2009-10-01 | Juvaris Biotherapeutics, Inc. | Enhancement of an immune response by administration of a cationic lipid-dna complex (cldc) |
US8251111B2 (en) | 2008-09-18 | 2012-08-28 | Premium Balloon Accessories, Inc. | Balloon inflator |
US8465748B2 (en) * | 2009-03-30 | 2013-06-18 | Matthias Giese | Vaccine compositions and methods containing an immunogen derived from equine arteritis virus |
EP2429581B1 (en) * | 2009-05-14 | 2015-08-05 | Bayer Intellectual Property GmbH | Enhanced immune response in avian species |
WO2012084951A1 (en) | 2010-12-22 | 2012-06-28 | Bayer Animal Health Gmbh | Enhanced immune response in bovine species |
MX2016010993A (es) * | 2014-02-28 | 2017-05-01 | Bayer Animal Health Gmbh | Plasmidos inmunoestimuladores. |
-
2016
- 2016-07-28 SG SG10202000891UA patent/SG10202000891UA/en unknown
- 2016-07-28 JP JP2018504671A patent/JP2018521109A/ja active Pending
- 2016-07-28 BR BR112018002107A patent/BR112018002107A2/pt active Search and Examination
- 2016-07-28 MX MX2018001251A patent/MX2018001251A/es unknown
- 2016-07-28 CN CN201680057074.6A patent/CN108025062A/zh active Pending
- 2016-07-28 KR KR1020187006085A patent/KR20180036765A/ko unknown
- 2016-07-28 WO PCT/EP2016/067971 patent/WO2017021266A1/en active Application Filing
- 2016-07-28 AU AU2016302436A patent/AU2016302436B2/en active Active
- 2016-07-28 US US15/748,444 patent/US11439703B2/en active Active
- 2016-07-28 EP EP16750416.6A patent/EP3328424A1/en not_active Withdrawn
- 2016-07-28 TW TW105123924A patent/TW201718001A/zh unknown
- 2016-07-28 CA CA2993883A patent/CA2993883A1/en not_active Abandoned
- 2016-08-01 AR ARP160102348A patent/AR105568A1/es unknown
-
2018
- 2018-01-17 IL IL256984A patent/IL256984A/en unknown
- 2018-01-25 PH PH12018500201A patent/PH12018500201A1/en unknown
- 2018-01-29 CL CL2018000253A patent/CL2018000253A1/es unknown
- 2018-02-27 ZA ZA2018/01338A patent/ZA201801338B/en unknown
- 2018-11-07 HK HK18114176.7A patent/HK1255052A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
PH12018500201A1 (en) | 2018-07-30 |
KR20180036765A (ko) | 2018-04-09 |
EP3328424A1 (en) | 2018-06-06 |
JP2018521109A (ja) | 2018-08-02 |
US11439703B2 (en) | 2022-09-13 |
IL256984A (en) | 2018-03-29 |
TW201718001A (zh) | 2017-06-01 |
WO2017021266A1 (en) | 2017-02-09 |
BR112018002107A2 (pt) | 2018-09-25 |
HK1255052A1 (zh) | 2019-08-02 |
AU2016302436B2 (en) | 2022-03-03 |
US20180326049A1 (en) | 2018-11-15 |
AR105568A1 (es) | 2017-10-18 |
CL2018000253A1 (es) | 2018-07-20 |
SG10202000891UA (en) | 2020-03-30 |
CN108025062A (zh) | 2018-05-11 |
CA2993883A1 (en) | 2017-02-09 |
AU2016302436A1 (en) | 2018-02-15 |
ZA201801338B (en) | 2021-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2017001406A (es) | Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva. | |
MA40061A (fr) | Compositions immunogènes à base de listeria pour provoquer des réponses anti-tumorales | |
MX2017008813A (es) | Polvo de coleopteros. | |
PH12018000197A1 (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
PH12016501968A1 (en) | Novel macrocyclic compounds | |
MX2021010060A (es) | Produccion de virus en huevos aviares. | |
MX2017002803A (es) | Coronavirus bovino atenuado y vacunas relacionadas. | |
PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
MX2017002890A (es) | Métodos y composiciones para potenciar respuestas inmunitarias. | |
PH12016502002B1 (en) | Novel bacteriophage and composition comprising same | |
PH12017500304A1 (en) | Vaccine compositions against dengue virus diseases | |
MY191539A (en) | Streptococcal vaccine | |
WO2016164619A3 (en) | Compositions and methods for the treatment of hbv infection | |
MX2023012390A (es) | Vacunacion con particulas de replicon y adyuvante oleoso. | |
EA201790517A1 (ru) | Способы и композиции для индуцирования защитного иммунитета против филовирусной инфекции | |
PH12018500201A1 (en) | Enhanced immune response in porcine species | |
MX2017003550A (es) | Uso de cisteamina en tratamiento de infecciones causadas por levaduras/mohos. | |
MX2018014955A (es) | Vacunas atenuadas vivas del virus de la influenza equina. | |
MX2017012389A (es) | Vacuna del virus de la parotiditis recombinante jeryl lynn2. | |
MX2021000508A (es) | Extracto de sabadilla seco y fluido. | |
MX2019010913A (es) | Analogos de deutetrabenazina, su preparacion y uso. | |
MX2016017084A (es) | Composiciones y metodos para mejorar la inmunidad. | |
MX2019002879A (es) | Compuestos novedosos y usos terapeuticos de los mismos. | |
MX2019003584A (es) | Proceso para la preparacion de la forma i de anhidrato de boscalid y la forma ii de anhidrato de boscalid. | |
MX2017009796A (es) | Mdv1 recombinantes y usos de los mismos. |